Articles Tagged With:
-
Elbasvir and Grazoprevir Tablets (Zepatier)
The FDA has approved another oral interferon-free regimen for the treatment of chronic hepatitis C (HCV) genotypes 1 and 4.
-
Payers claim procedures weren’t medically necessary
With medical necessity denials, “prior authorization is ‘job-one,’” says John Holyoak, director of product management at RelayHealth Financial, which is based in Alpharetta, GA.
-
Did payer deny claim? Look closely to see if contract allows it
Many patient access leaders are seeing a sharp increase in claims denials, primarily due to more numerous and stringent payer requirements.
-
Should Postmenopausal Women Be Encouraged to Take Calcium?
A systematic review of randomized, controlled trials of calcium supplementation found only small non-progressive increases in bone mineral density. This supports the clinical conclusion that supplementation alone is insufficient to prevent fracture risk.
-
Association of Coffee Consumption with Total and Cause-specific Mortality
Regular consumption of both caffeinated and decaffeinated coffee were found to be inversely associated with risk of total mortality and mortality attributed to cardiovascular disease and neurologic diseases.
-
High Blood Pressure: How Low Should We Go? SPRINT and a New Meta-analysis
A recent meta-analysis supports the benefit of targeting lower blood pressure levels.
-
Rolling Along: ACA and Medicaid Beneficiaries Report Record Savings
Medicare and the Affordable Care Act have helped millions of people save billions of dollars on prescription drugs. -
Doctors Play Key Role in Ending the Opioid Addiction Epidemic
Primary care physicians are under fire for contributing to the problem of prescription opioid abuse.
-
Plaintiff Attorney Could Argue ED Was Unprepared for Mass Shooting
An expert warns that an ED's failure to prepare for mass shooting events might not only risk patient safety, but could also result in liability risks to the hospital and EPs.
-
Many Crowded EDs Have Not Adopted Proven Solutions that Address Problem
Researchers worry a crowded ED is now the new status quo, which reduces the incentive to change.